Jonathan Schönbäck is based in Stockholm and has worked at Handelsbanken since 2006. He is responsible for managing the Handelsbanken Sverige Selectiv (A1) Fund dealing in Swedish equities, using a quality investment style. Jonathan graduated from Uppsala University with an MSc in Economics and outside of work he enjoys skiing, tennis, music and the theatre.
The fund is an actively managed equity fund. It is a special fund, which for this fund means it can invest in a limited number of companies. The Fund invests a substantial portion of assets (max. 50%) in AstraZeneca company but also in other shares issued by companies in Sweden and the Nordic countries. Derivatives such as futures can also be invested in.